An overview of cyclopropenone derivatives as promising bioactive molecules

被引:0
作者
Jin, Sasa [1 ]
He, Zhangxu [1 ]
Du, Yuanbing [1 ]
Jin, Gang [1 ]
Wang, Kaiyue [1 ]
Yang, Feifei [1 ]
Zhang, Jingyu [1 ]
机构
[1] Henan Univ Chinese Med, Pharm Coll, Zhengzhou 450046, Peoples R China
基金
中国博士后科学基金;
关键词
Cyclopropenone; Diphenylcyclopropenone; Triple negative breast cancer; Melanoma; Alopecia areata; METASTATIC MALIGNANT-MELANOMA; TOPICAL IMMUNOTHERAPY; ALOPECIA-AREATA; DIPHENCYPRONE; DIPHENYLCYCLOPROPENONE; INHIBITORS; REGRESSION;
D O I
10.1016/j.bmcl.2024.129845
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclopropenone is a valuable electrophilic reagent that can react with electrophilic reagents, nucleophilic reagents, free radicals, organic metals, etc. Furthermore, cyclopropenone derivatives have shown significant biological activity in various diseases, such as triple -negative breast cancer (TNBC), melanoma, and alopecia areata (AA). The cyclopropenone analogue diphenylcyclopropenone (DPCP) has been approved for the treatment of AA. Given the potential therapeutic benefits of cyclopropenone derivatives, this review aims to systematically summarize the structures, synthesis routes, and potential pharmacological functions of cyclopropenone analogues in the hope of offering novel insights for further rational design of more drugs based on the cyclopropenone skeleton for the treatment of human diseases.
引用
收藏
页数:7
相关论文
共 52 条
  • [1] Heterocycles from cyclopropenones
    Aly, Ashraf A.
    Hassan, Alaa A.
    Mostafa, Sara M.
    Mohamed, Asmaa. H.
    Osman, Esraa M.
    Nayl, AbdElAziz A.
    [J]. RSC ADVANCES, 2022, 12 (29) : 18615 - 18645
  • [2] A NEW CLASS OF PROTEINASE-INHIBITOR - CYCLOPROPENONE-CONTAINING INHIBITOR OF PAPAIN
    ANDO, R
    MORINAKA, Y
    TOKUYAMA, H
    ISAKA, M
    NAKAMURA, E
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1993, 115 (03) : 1174 - 1175
  • [3] Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities
    Ando, R
    Sakaki, T
    Morinaka, Y
    Takahashi, C
    Tamao, Y
    Yoshii, N
    Katayama, S
    Saito, K
    Tokuyama, H
    Isaka, M
    Nakamura, E
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (04) : 571 - 579
  • [4] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-RESTRICTED CD8(+) T-CELLS AND CLASS II-RESTRICTED CD4(+) T-CELLS, RESPECTIVELY, MEDIATE AND REGULATE CONTACT SENSITIVITY TO DINITROFLUOROBENZENE
    BOUR, H
    PEYRON, E
    GAUCHERAND, M
    GARRIGUE, JL
    DESVIGNES, C
    KAISERLIAN, D
    REVILLARD, JP
    NICOLAS, JF
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (11) : 3006 - 3010
  • [5] DIPHENYLCYCLOPROPENONE
    BRESLOW, R
    EICHER, T
    KREBS, A
    PETERSON, RA
    POSNER, J
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1965, 87 (06) : 1320 - &
  • [6] CYCLOPROPENONE
    BRESLOW, R
    RYAN, G
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1967, 89 (12) : 3073 - &
  • [7] SUBSTITUTED CYCLOPROPENONES
    BRESLOW, R
    ALTMAN, LJ
    KREBS, A
    MOHACSI, E
    MURATA, I
    PETERSON, RA
    POSNER, J
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1965, 87 (06) : 1326 - &
  • [8] Buckley DA, 1999, INT J CLIN PRACT, V53, P130
  • [9] Difluorocarbene chemistry:: A simple transformation of 3,3-gem-difluorocyclopropenes to cyclopropenones
    Cheng Zhan-Ling
    Chen Qing-Yun
    [J]. CHINESE JOURNAL OF CHEMISTRY, 2006, 24 (09) : 1219 - 1224
  • [10] Peptidyl cyclopropenones: Reversible inhibitors, irreversible inhibitors, or substrates of cysteine proteases?
    Cohen, Meital
    Bretler, Uriel
    Albeck, Amnon
    [J]. PROTEIN SCIENCE, 2013, 22 (06) : 788 - 799